| BMC | Benchmark Concentration |
| BMR | Benchmark Response |
| cMINC | Neural Crest Cell Migration Assay |
| CYP | Cytochrome P450 (enzyme family) |
| DNT | Developmental Neurotoxicity |
| DNT-IVB | Developmental Neurotoxicity In Vitro Battery |
| DoM | Day of Migration |
| EC | Effect Concentration |
| FMO | Flavin-containing Monooxygenase |
| G6P | Glucose-6-phosphate |
| HLM | Human Liver Microsomes |
| HPP+ | Haloperidol Pyridinium Ion |
| KNDP | Key Neurodevelopmental Processes |
| LUHMES | Foetal Human Mesencephalic Cell Line |
| MDMA | Methylenedioxymethamphetamine |
| MitoMet | Mitochondrial Toxicity Assay Variant of NeuriTox |
| MPP+ | 1-methyl-4-phenylpyridinium |
| MPTP | 1-methyl-4-phenyl-tetrahydropyridine |
| NAM | New Approach Methodology |
| NCC | Neural Crest Cell |
| NGRA | Next-Generation Risk Assessment |
| S9 | Post-Mitochondrial Supernatant Fraction |